| APOC1 |
| LOCUS ID | 341 | ||||||||||
| GENE_SYMBOL | APOC1 | ||||||||||
| GENE NAME | apolipoprotein C-I | ||||||||||
| SYNONYMNS | Apo-CI, ApoC-I | ||||||||||
| CHROMOSOME | 19 | ||||||||||
| HOMOLOGENE ID | 136749 |
| microRNAs | NA | NA |
| GENE SUMMARY |
|---|
| The protein encoded by this gene is a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Altertively spliced transcript variants have been found for this gene, but the biological validity of some varian |
| OBSERVATIONS |
|---|
| Complication | Evidence | PMID |
| Nephropathy | 1. We identified 34 replicated genetic variants. Of these, 21 remained significantly associated with diabetic nephropathy in a random-effects meta-analysis. These variants were in or near the following genes ACE, AKR1B1 (two variants), APOC1, APOE, EPO, NOS3 (two variants), HSPG2, VEGFA, FRMD3 (two variants), CARS (two variants), UNC13B, CPVL and CHN2, and GREM1, plus four variants not near genes. The odds ratios of associated genetic variants ranged from 0.48 to 1.70. Additional variants were detected in subgroup analyses ELMO1 (Asians), CCR5 (Asians) and CNDP1 (type 2 diabetes). | 21127830 |